VitaNova Life Sciences (VNOV) Non Operating Income (2021 - 2026)

VitaNova Life Sciences has disclosed Non Operating Income across 4 years of filings, most recently posting $2860.0 for Q2 2026.

• Non Operating Income for Q2 2026 came in at $2860.0, up 282.4% year-over-year; the trailing twelve-month figure through Apr 2026 was $1412.0 (up 136.16% YoY), and the FY2026 annual result was $2980.0, up 174.31% from the prior year.
• Non Operating Income for Q2 2026 stood at $2860.0, up from $120.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $2860.0 in Q2 2026 and bottomed at -$1825.0 in Q4 2024.
• Average Non Operating Income over 3 years is -$154.17, with a median of -$256.0 recorded in 2024.
• The widest annual swing landed in 2025, when Non Operating Income sank 1593.33%; it then soared 282.4% in 2026.
• Year by year, Non Operating Income stood at -$1825.0 in 2024, then soared by 106.58% to $120.0 in 2025, then surged by 2283.33% to $2860.0 in 2026.
• The last three Non Operating Income figures came in at $2860.0 (Q2 2026), $120.0 (Q4 2025), and -$1568.0 (Q2 2025), per Business Quant data.